F rom June 2007 the complete archive of Annals of the Rheumatic Diseasesthe Eular journal will be available online www.ard.bmj.com -that's all issues from January 1939 to today. In keeping with the BMJ Group's delayed free access policy all content older than 12 month's is free to non-subscribers, including the newly digitised legacy content.
ARD was the first international rheumatology journal in English, so it attracted prominent authors, and their papers gave the first global mirror of rheumatology in Europe and North America as long ago as 1939. Interestingly, in the very first issue of the journal 6 of the 10 papers were about infections in relation to rheumatism. Other noteworthy articles include an authoritative overview of rheumatic diseases by Philip Hench -to date the only Nobel Prize winner in the field of rheumatology, Ludwig Aschoff's paper on rheumatic nodules in the heart and W S Tegner's paper on the treatment of the rheumatic diseases in the United States and Europe, even in the light of today's rheumatology, a highly interesting travel report.
The legacy content is an immense addition to an already rich site. 1 As well as being able to search and browse the complete Annals archive you can: 
MORE FEATURES
The Annals is one of the world's leading rheumatology journals with an impact factor of 6.956 and global reach. Each print issue is sent to approximately 10 000 subscribers and there are about 100 000 visitors to ARD Online each month. The journal attracts world class research and the high rejection rate ensures only the best is published. N ARD offers fast peer review with a median time to first decision of just 5 weeks using online submission and review 3 N ARD Online First 4 gets research into the public domain within 2 weeks of acceptance -and indexed by PubMed a few days later N The Unlocked option 5 allows authors to make papers free from the point of publication N Authors retain copyright and have liberal rights of reuse without permission, they also receive a royalty of large commercial reprint sales 6 N Our active press release programme helps get selected research to a very wide international audience
